A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
Aaron B WaxmanDepartment of Internal Medicine, Pulmonary Critical Care Unit, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USAAbstract: Pulmonary arterial hypertension (PAH) is a life threatening, progressive condition which eventually leads to fatal right heart failure. Endoth...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2007-03-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/a-review-of-sitaxsentan-sodium-in-patients-with-pulmonary-arterial-hyp-peer-reviewed-article-VHRM |